Accessibility Menu
Cresco Labs logo

Cresco Labs

(OTC) CRLBF

Current Price$0.76
Market Cap$281.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-82%
5 Year-93%
1 Year+9%
1 Month-14%

Cresco Labs Financials at a Glance

Market Cap

$281.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$641.80M

Net Income (TTM)

-$136.60M

EPS (TTM)

-$0.37

P/E Ratio

-2.04

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$0.76

Volume

315,660

Open

$0.75

Previous Close

$0.76

Daily Range

$0.75 - $0.79

52-Week Range

$0.50 - $2.30

Estimated Earnings Date

Aug 6, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cresco Labs

Industry

Pharmaceuticals

Employees

2,900

CEO

Charles Bachtell

Headquarters

Chicago, IL 60661, US

CRLBF Financials

Key Financial Metrics (TTM)

Gross Margin

48.57%

Operating Margin

10.41%

Net Income Margin

-21.28%

Return on Equity

-35.26%

Return on Capital

10.74%

Return on Assets

-11.36%

Earnings Yield

-49.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$281.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

371.00M

Volume

315.66K

Avg. Volume

764.33K

Financials (TTM)

Gross Profit

$311.73M

Operating Income

$66.80M

EBITDA

$108.21M

Operating Cash Flow

$37.32M

Capital Expenditure

-$37.54M

Free Cash Flow

-$219.72K

Cash & ST Invst.

$63.78M

Total Debt

$588.71M

Cresco Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$149.23M

-10.0%

Gross Profit

$69.55M

-11.5%

Gross Margin

46.61%

N/A

Market Cap

$281.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$99.77K

N/A

Employees

2,826

N/A

Net Income

-$12.89M

+10.7%

EBITDA

$28.54M

-3.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$63.78M

-58.9%

Total Debt

$588.71M

-8.8%

Accounts Receivable

$38.27M

-15.1%

Inventory

$108.80M

+25.2%

Long Term Debt

$564.83M

-7.9%

Short Term Debt

$23.80M

-27.4%

Return on Assets

-11.36%

N/A

Return on Invested Capital

6.05%

N/A

Free Cash Flow

-$13.09M

-155.9%

Operating Cash Flow

-$5.55M

-118.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NWBONorthwest Biotherapeutics, Inc.
$0.18+2.16%
PTCHFPureTech Health plc
$1.60+0.00%
VRNOFVerano Holdings Corp.
$1.30+8.33%
ABTIAlterola Biotech, Inc.
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PATHUiPath
$11.68-0.01%
FRMIFermi
$6.59-0.10%
ONDSOndas
$7.26-0.05%
NOKNokia
$12.44-0.04%

Questions About CRLBF

What is the current price of Cresco Labs?

Cresco Labs is trading at $0.76 per share.

What is the 52-week range for Cresco Labs?

Over the past 52 weeks, Cresco Labs has traded between $0.50 and $2.30.

How much debt does Cresco Labs have?

As of the most recent reporting period, Cresco Labs reported total debt of $586.78M.

How much cash does Cresco Labs have on hand?

Cresco Labs reported $63.57M in cash and cash equivalents in its most recent financial results.

What is Cresco Labs’s dividend yield?

Cresco Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.